Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy
Open Access
- 15 January 1996
- Vol. 77 (2), 292-300
- https://doi.org/10.1002/(sici)1097-0142(19960115)77:2<292::aid-cncr11>3.0.co;2-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6European Journal Of Cancer, 1994
- MDR1 gene expression and prognostic factors in primary breast carcinomasEuropean Journal of Cancer and Clinical Oncology, 1991
- Clinical Relevance of Immunohistochemical Detection of Multidrug Resistance P-Glycoprotein in Breast CarcinomaJNCI Journal of the National Cancer Institute, 1991
- Molecular and Cellular Biology of Multidrug Resistance in Tumor CellsPublished by Springer Science and Business Media LLC ,1991
- P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodiesBritish Journal of Cancer, 1990
- Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or MoreJNCI Journal of the National Cancer Institute, 1990
- Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancerHuman Pathology, 1990
- Correlation of Pretreatment Proliferative Activity of Breast Cancer With the Response to Cytotoxic ChemotherapyJNCI Journal of the National Cancer Institute, 1989
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989
- Expression of a multidrug-resistance gene in human tumors and tissues.Proceedings of the National Academy of Sciences, 1987